Search Results - Nekljudova, V.
- Showing 1 - 7 results of 7
-
1
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2-breast cancer and residual disease after neoadjuvant... by Loibl, Sibylle (Author) , Martin, M. (Author) , Bonnefoi, H. (Author) , Untch, M. (Author) , Kim, S. -B. (Author) , Bear, H. D. (Author) , García-Sáenz, J. A. (Author) , Melé Olivé, M. (Author) , Mc Carthy, N. (Author) , Gelmon, K. (Author) , Kelly, C. M. (Author) , Im, S. -A. (Author) , Reimer, T. (Author) , Martinez-Janez, M. (Author) , Zhang, Z. (Author) , Toi, M. (Author) , Provencher, L. (Author) , Rugo, H. S. (Author) , Gnant, M. (Author) , Makris, A. (Author) , Antón Torres, A. (Author) , Hirmas, N. (Author) , Holtschmidt, J. (Author) , Nekljudova, V. (Author) , Marmé, Frederik (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-n... by Meyer-Wilmes, Philipp (Author) , Huober, Jens (Author) , Untch, Michael (Author) , Blohmer, J. -U. (Author) , Janni, W. (Author) , Denkert, Carsten (Author) , Klare, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Bayer, C. (Author) , Reinisch, M. (Author) , Bjelic-Radisic, V. (Author) , Zahm, Dirk-Michael (Author) , Hanusch, Claus Alexander (Author) , Solbach, C. (Author) , Heinrich, G. (Author) , Hartkopf, A. D. (Author) , Schneeweiss, Andreas (Author) , Fasching, Peter Andreas (Author) , Filmann, N. (Author) , Nekljudova, V. (Author) , Holtschmidt, J. (Author) , Stickeler, E. (Author) , Loibl, Sibylle (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup ana... by Marmé, Frederik (Author) , Martin, M. (Author) , Untch, M. (Author) , Thode, C. (Author) , Bonnefoi, H. (Author) , Kim, S. -B. (Author) , Bear, H. (Author) , Mc Carthy, N. (Author) , Gelmon, K. (Author) , García-Sáenz, J. A. (Author) , Kelly, C. M. (Author) , Reimer, T. (Author) , Valota, O. (Author) , Toi, M. (Author) , Rugo, H. S. (Author) , Gnant, M. (Author) , Makris, A. (Author) , Bassy, M. (Author) , Zhang, Z. (Author) , Furlanetto, J. (Author) , Nekljudova, V. (Author) , Loibl, S. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
4
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response by Loibl, Sibylle (Author) , Schneeweiss, Andreas (Author) , Huober, J. (Author) , Braun, M. (Author) , Rey, J. (Author) , Blohmer, J. -U. (Author) , Furlanetto, J. (Author) , Zahm, D. -M. (Author) , Hanusch, C. (Author) , Thomalla, J. (Author) , Jackisch, C. (Author) , Staib, P. (Author) , Link, T. (Author) , Rhiem, K. (Author) , Solbach, C. (Author) , Fasching, P. A. (Author) , Nekljudova, V. (Author) , Denkert, C. (Author) , Untch, M. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
5
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆ by Denkert, Carsten (Author) , Untch, M. (Author) , Benz, S. (Author) , Schneeweiss, Andreas (Author) , Weber, K. E. (Author) , Schmatloch, S. (Author) , Jackisch, C. (Author) , Sinn, Peter (Author) , Golovato, J. (Author) , Karn, T. (Author) , Marmé, Frederik (Author) , Link, T. (Author) , Budczies, Jan (Author) , Nekljudova, V. (Author) , Schmitt, W. D. (Author) , Stickeler, E. (Author) , Müller, V. (Author) , Jank, P. (Author) , Parulkar, R. (Author) , Heinmöller, E. (Author) , Sanborn, J. Z. (Author) , Schem, C. (Author) , Sinn, Bruno (Author) , Soon-Shiong, P. (Author) , van Mackelenbergh, M. (Author) , Fasching, P. A. (Author) , Rabizadeh, S. (Author) , Loibl, S. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
6
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized c... by Llop-Guevara, Alba (Author) , Loibl, Sibylle (Author) , Villacampa, G. (Author) , Vladimirova, V. (Author) , Schneeweiss, Andreas (Author) , Karn, T. (Author) , Zahm, D. -M. (Author) , Herencia-Ropero, A. (Author) , Jank, P. (Author) , Mackelenbergh, M. van (Author) , Fasching, P. A. (Author) , Marmé, Frederik (Author) , Stickeler, E. (Author) , Schem, C. (Author) , Dienstmann, R. (Author) , Florian, S. (Author) , Nekljudova, V. (Author) , Balmaña, J. (Author) , Hahnen, E. (Author) , Denkert, C. (Author) , Serra, V. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
7
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto by Loibl, Sibylle (Author) , Weber, K. E. (Author) , Timms, K. M. (Author) , Elkin, E. P. (Author) , Hahnen, K. (Author) , Fasching, P. A (Author) , Lederer, B. (Author) , Denkert, A. (Author) , Schneeweiss, Andreas (Author) , Braun, S (Author) , Salat, C. T. (Author) , Rezai, M. (Author) , Blohmer, J. U. (Author) , Zahm, D. M. (Author) , Jackisch, B (Author) , Gerber, Bernd (Author) , Klare, P. (Author) , Kümmel, S (Author) , Schem, C. (Author) , Paepke, S. (Author) , Schmutzler, R. (Author) , Rhiem, K. (Author) , Penn, S. (Author) , Reid, J. (Author) , Nekljudova, V. (Author) , Hartman, A.-R. (Author) , Minckwitz, von G. (Author) , Untch, M. (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
breast cancer
palbociclib
survival
,
HER2 negative
HER2-negative
HR-positive/HER2-negative breast cancer
HRD biomarkers
PENELOPE-B
RAD51
adjuvant CDK4/6 inhibitor
cabazitaxel
checkpoint inhibitor
durvalumab
early breast cancer
early triple-negative breast cancer
high-risk patients
hormone receptor positive
mutational signatures
neoadjuvant chemotherapy
neoadjuvant therapy
ovarian function
overall survival
paclitaxel
personalized medicine
platinum-based neoadjuvant chemotherapy
premenopausal
prognosis
response
triple-negative breast cancer